Jefferies kept a Hold rating on Gerresheimer stock at EUR 26.80
Published on 10/08/2026 at 13:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Jefferies kept a Hold rating on Gerresheimer stock with a EUR 26.80 price target on September 30, 2026, according to finanznachrichten.de. The analyst view arrived as Gerresheimer's second-quarter recovery improved sequentially but the balance sheet remained a central risk.
Three milestones shape the recovery
On July 29, 2026, Gerresheimer signed agreements covering Centor and Primary Packaging Plastics at a combined enterprise value of EUR 1.5 billion, EQS News reported. On September 30, 2026, second-quarter revenue reached EUR 578 million, down 5.86 percent from EUR 614 million a year earlier, while adjusted EBITDA rose 52.24 percent from EUR 67 million to EUR 102 million, according to Investing.com.
On October 1, 2026, Gerresheimer completed the Centor sale and said the proceeds would reduce debt, while the Primary Packaging Plastics transaction remained targeted for the first half of 2027, according to EQS News. The sequence matters because asset sales are intended to address leverage while operations recover from a weak first quarter.
What does the sale change?
The Q2 improvement was substantial sequentially, but it did not erase the annual comparison: revenue fell 5.86 percent year over year and adjusted EBITDA declined from EUR 122 million in the second quarter of 2025 to EUR 102 million in the second quarter of 2026. Investing.com reported negative free cash flow before mergers and acquisitions of EUR 92 million in the second quarter of 2026, making debt reduction and execution on the divestitures important financial markers.
Jefferies also highlighted higher net debt and lower liquidity on September 30, 2026. Its EUR 26.80 target sits below the Lang & Schwarz price of EUR 29.04, so the analyst's Hold stance contrasts with the market's position above that target.
Next dates and the stock
Gerresheimer's investor-relations calendar lists the half-year report for November 2026 and the third-quarter results for December 2026. The company also lists the Berenberg European Conference for December 2, 2026, giving investors three dated milestones for monitoring the debt reduction plan and the second-half recovery.
Gerresheimer was trading at EUR 29.04 at Lang & Schwarz on October 8, 2026 at 1:39 p.m. CEST, plus 0.55 percent versus the prior close of EUR 28.88 on October 7, 2026. The primary Xetra listing showed a 52-week range of EUR 14.83 to EUR 33.88 and a market capitalization of EUR 1.0 billion as of October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.
Gerresheimer stock facts
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Primary exchange: Xetra
- Price Lang & Schwarz as of October 8, 2026, 1:39 p.m. CEST: EUR 29.04
- Change versus prior close: plus 0.55 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 28.88
- Market capitalization: EUR 1.0 billion as of October 8, 2026
- 52-week range: EUR 14.83-EUR 33.88 as of October 8, 2026
- Sector: Health Care
Market context: Market report DAX.
